← Back to Search

Treatment for Frontotemporal Dementia

N/A
Recruiting
Led By Bradley Boeve, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 year, 2 year, 3 year, 4 year, 5 year
Awards & highlights

Summary

This trial is for a research consortium studying frontotemporal lobar degeneration (FTLD), a type of dementia. The study will last for 2019 and beyond.

Eligible Conditions
  • Gene Mutation
  • Frontotemporal Dementia
  • TBK1 Gene
  • Progressive Supranuclear Palsy
  • Frontotemporal Lobar Degeneration
  • Corticobasal Degeneration
  • Primary Progressive Aphasia
  • Amyotrophic Lateral Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 year, 2 year, 3 year, 4 year, 5 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 year, 2 year, 3 year, 4 year, 5 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Brain Volumes
Change in Multidomain Impairment Rating (MIR) Scale
Change in NIH Examiner Executive Composite Score
Secondary outcome measures
Plasma Neurofilament Light Chain Analysis

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,298 Previous Clinical Trials
3,956,345 Total Patients Enrolled
12 Trials studying Frontotemporal Dementia
10,150 Patients Enrolled for Frontotemporal Dementia
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,362 Previous Clinical Trials
648,650 Total Patients Enrolled
13 Trials studying Frontotemporal Dementia
5,178 Patients Enrolled for Frontotemporal Dementia
University of California, San FranciscoOTHER
2,551 Previous Clinical Trials
15,255,786 Total Patients Enrolled
15 Trials studying Frontotemporal Dementia
6,116 Patients Enrolled for Frontotemporal Dementia
~267 spots leftby Jun 2025